UCB – Rare Disease
July 24, 2025 |
UCB is a global biopharmaceutical company committed to developing innovative solutions to address significant unmet needs for people living with severe diseases. We put patients at the heart of everything we do by incorporating the individual experiences of patients and caregivers into the discovery, development, and delivery of our medicines. Our purpose is to create value for patients, their families and society by elevating lives through our medicines now and in the future. For decades, we’ve focused on creating solutions for people living with neurological and immunological diseases, advancing medicines that significantly improve lives.